Free Trial
NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo
$101.01 +0.03 (+0.03%)
Closing price 08/14/2025
Extended Trading
$101.01 0.00 (0.00%)
As of 08/14/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$100.93
$101.02
50-Day Range
$95.96
$101.01
52-Week Range
$82.15
$101.02
Volume
1.06 million shs
Average Volume
780,222 shs
Market Capitalization
$3.32 billion
P/E Ratio
39.30
Dividend Yield
N/A
Price Target
$100.50
Consensus Rating
Moderate Buy

Company Overview

Amedisys Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

AMED MarketRank™: 

Amedisys scored higher than 61% of companies evaluated by MarketBeat, and ranked 381st out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amedisys has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Amedisys has received no research coverage in the past 90 days.

  • Read more about Amedisys' stock forecast and price target.
  • Earnings Growth

    Earnings for Amedisys are expected to grow by 10.00% in the coming year, from $4.40 to $4.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amedisys is 39.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.63.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amedisys is 39.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.27.

  • Price to Earnings Growth Ratio

    Amedisys has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Amedisys has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Amedisys' valuation and earnings.
  • Percentage of Shares Shorted

    9.96% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Amedisys has recently increased by 42.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Amedisys does not currently pay a dividend.

  • Dividend Growth

    Amedisys does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.96% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 6.6.
  • Change versus previous month

    Short interest in Amedisys has recently increased by 42.86%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Amedisys has a news sentiment score of 1.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Amedisys this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for AMED on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Amedisys to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Amedisys insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Amedisys is held by insiders.

  • Percentage Held by Institutions

    94.36% of the stock of Amedisys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Amedisys' insider trading history.
Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

AMED Stock News Headlines

Head to Head Contrast: Amedisys (NASDAQ:AMED) & DaVita (NYSE:DVA)
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel
Amedisys Completes Merger and Delists from Nasdaq
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys' stock was trading at $90.79 on January 1st, 2025. Since then, AMED stock has increased by 11.3% and is now trading at $101.01.

Amedisys, Inc. (NASDAQ:AMED) issued its earnings results on Tuesday, July, 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.15. The company's quarterly revenue was up 5.2% compared to the same quarter last year.

Amedisys' top institutional investors include Alpine Associates Management Inc. (3.34%), State Street Corp (3.25%), Norges Bank (2.74%) and Qube Research & Technologies Ltd (2.40%).
View institutional ownership trends
.

Shares of AMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
7/29/2025
Today
8/25/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:AMED
CIK
896262
Employees
19,000
Year Founded
1982

Price Target and Rating

High Price Target
$101.00
Low Price Target
$100.00
Potential Upside/Downside
-0.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.57
Trailing P/E Ratio
39.30
Forward P/E Ratio
22.96
P/E Growth
1.34
Net Income
$43.23 million
Net Margins
3.56%
Pretax Margin
6.21%
Return on Equity
12.91%
Return on Assets
7.29%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
1.36
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$2.40 billion
Price / Sales
1.38
Cash Flow
$6.24 per share
Price / Cash Flow
16.20
Book Value
$38.77 per share
Price / Book
2.61

Miscellaneous

Outstanding Shares
32,887,000
Free Float
32,196,000
Market Cap
$3.32 billion
Optionable
Optionable
Beta
0.89

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners